Review of Features, Treatment Options in Peripheral T-Cell Lymphoma
Combined targeted agents with immune regulators and chimeric antigen receptor cell–based therapies may improve overall survival for patients with PTCL.
Diagnosis & Disease Information
Treatment Characteristics and Outcomes for Patients With Rare Forms of T-Cell Lymphoma
Researchers characterized outcomes for enteropathy-associated T-cell lymphoma, hepatosplenic T-cell lymphoma, and peripheral gamma delta T-cell lymphoma.
Carbapenem Reduces Tumor Burden in Patients With Cutaneous T-Cell Lymphomas and Bacterial Infection
Antibiotic treatment with carbapenem for S. aureus infection was efficacious in patients with cutaneous T-cell lymphomas.
Determining Optimal Consolidation for First-Line Peripheral T-Cell Lymphoma Therapy
Current guidelines support autologous transplantation for consolidation in transplant-eligible patients with peripheral T-cell lymphoma.
Autologous Stem Cell Transplantation Outcomes in Patients With Peripheral T-Cell Lymphomas
Patients with higher International Prognostic Index scores or advanced-stage disease experienced improved survival when treated with ASCT.
Updated WHO-EORTC Classification for Primary Cutaneous Lymphomas
Changes to the WHO-EORTC classification for primary cutaneous lymphomas were highlighted in a recent review article.
Adcetris Plus Chemotherapy Approved for Peripheral T-Cell Lymphoma
The approval was based on data from a randomized, double-blind, double-dummy, actively controlled trial (ECHELON-2) involving 452 patients with certain PTCLs.
Standard Methodology Needed to Evaluate Pruritus in Cutaneous T Cell Lymphoma
Though the majority of patients with cutaneous T cell lymphomas experience pruritus, the pathophysiology of the symptom is relatively unclear.
5-Azacitidine May Lead to Sustained Response in Peripheral T-Cell Lymphoma
Patients with peripheral T-cell lymphomas have a median overall survival of approximately 6 months.
EFS May Be A Surrogate for Overall Survival in Peripheral T Cell Lymphomas
Previous study suggests that EFS is a prognostically relevant variable among patients with other lymphomas; for this study, researchers evaluated whether EFS24 predicts for overall survival in PTCL.
- Loading...
Loading...
Loading... 
Loading...